This section presents pharmaceutical projects that are announced from time-to-time around the world.

Boehringer Ingelheim Announces US$260 million Investment into new Biologicals Development Center

Introduction Boehringer Ingelheim announced a US260 million investment into a new Biological Development Center BDC at the companys Research and Development site in Biberach Germany Features The BDC will help to maximise by integrating Biologicals analytical and process development as well ..

Wuxi Biologics to Invest US$60 million to Build a Biologics Manufacturing Unit in Singapore

Introduction Wuxi Biologics plans to invest US60 million in establishing a stateoftheart biologics manufacturing facility in Singapore Features The manufacturing facility will be arranged with singleuse bioreactors at the nextgeneration facility It is majorly designed to support continuous ..

Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility

Introduction Lonza opens the worlds largest dedicated cellandgenetherapy facility in Pearland Greater Houston TX USA Features The facility was built in anticipation of the rising demand from developers of cell and gene therapies and with the mission of enabling them to deliver these types o..

Sterling Pharma Solutions to Invest US$8 million in Pilot Plant Facility at its UK Site

Introduction Contract Development and Manufacturing Organisation CDMO Sterling Pharma Solutions is investing US8 million into its pilot plant facility at its UK site Features The facility will enhance the pilot plants capacity by 33 per cent and increase the sites production capabilities an..

WuXi Biologics Plans to Invest US$ 382 million to Build Largest Biomanufacturing Facility Centre in Ireland

Introduction WuXi Biologics announces to make an investment of US382 million to construct a largest Biomanufacturing facility centre in Ireland using singleuse biologics approach Features The Biomanufacturing facility centre is proposed to get constructed on the 26hectare campus of WuXi Bio..

Catalent Pharma Announces US$5 million Expansion Plan to Create New Drug Development Centre of Excellence at Somerset Site

Introduction Catalent Pharma Solutions made an announcement to investment US5 million towards construction of a new drug development and modified release centre of excellence at its Somerset site Features Catalent Pharma Solutions is planning to invest US5 million to establish a new drug de..

Sanofi to Invest US$410 million in State-of-the-Art Vaccine Facility at Canada

Introduction Sanofi Pasteur announced its US 410 million investment plan for the construction of a new stateoftheart vaccine manufacturing facility centre at its Canadian headquarters in Toronto Features The new facility will allow Sanofi Pasteur to increase its capacity to meet the growing..

Amgen Plans to Build Next-Gen Biomanufacturing Plant in Rhode Island

Introduction Amgen is planning to build a new stateoftheart nextgeneration Biomanufacturing plant at its campus in West Greenwich Rhode Island The new plant will be firstofitskind in the US Features With the track record of providing a reliable supply of highstandard medicines for patients ..

Thermo Fisher’s to Invest US$35 million to Construct State-of-the-Art Pharma Facility Centre in Rheinfelden

Introduction Thermo Fisher Scientific announced its US 35 million expansion plan to build a stateoftheart pharma services supply chain facility in Rheinfelden Baden Germany Features Thermo Fisher Scientific is planning to begin the construction of its 8000sq meter pharma service facility ce..

Ferring Announces US$30 million Expansion Plan of New Biotech Centre in Switzerland

Introduction Ferring Pharmaceuticals made a US30 million investment announcement of expanding its capabilities in biologics through a new biotech centre at its global headquarters and manufacturing site in St Prex Switzerland Features Ferring Pharmaceuticals is planning to integrate discove..